As the UAE continues to build a world-class healthcare system and enhance its pharmaceutical self-sufficiency, Mubadala Bio has taken a significant step forward in supporting national drug security. The company has announced the introduction of eight new essential medicines produced locally through its subsidiaries, reinforcing its mission to deliver better health outcomes across the country and the wider region.

The launch marks another milestone in Mubadala Bio’s ongoing efforts to advance the UAE’s ambition of becoming a regional hub for life sciences. It contributes to strengthening the country’s drug security, improving access to vital therapies, and fostering a sustainable, knowledge-based economy.

The newly introduced medicines are already in high demand across hospitals, clinics, and pharmacies—include:

• Rivaroxaban, an anticoagulant used to prevent blood clots in the brain and other blood vessels

• Linezolid, an antibiotic for drug-resistant bacterial infections

• Sugammadex, used to aid anesthesia recovery after surgery

• Fluconazole, an antifungal for serious infections

• Pantoprazole and Ondansetron, both injectable therapies to manage stomach acid and prevent nausea during cancer treatment

• Bupivacaine, a long-acting local anesthetic

• Sodium Chloride Inhalation Solution, used to clear airways and mucus in the lungs.

These medicines are now being manufactured at Mubadala Bio’s UAE facilities like Gulf Inject, Wellpharma, and Bioventure Healthcare and are helping to ensure a stable and reliable supply of critical therapies.

Dr. Bakheet Al Katheeri, CEO of Mubadala’s UAE Investments Platform and Chairman of Mubadala Bio, said, “As a national champion, Mubadala Bio was launched to strengthen the UAE’s life sciences sector and to enable local production of essential medications…”

With operations across three continents, Mubadala Bio produces over 10,000 pharmaceutical products distributed to more than 100 countries, cementing its position as a key player in the global life sciences industry.